University of Hawaii
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Hawaii sits in the top decile of US sponsors by registered trial count (#284 of 15,742 sponsors by registered trial count).
University of Hawaii: 77 sponsored US clinical trials, 13 recruiting.
University of Hawaii sponsors 77 registered US clinical trials on ClinicalTrials.gov, 13 of them currently recruiting, and 51 completed. 4 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 4 trials.
Top-decile sponsor footprint
University of Hawaii ranks in the top decile of sponsors by registered trial count (#284 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
51 of 56 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
77 total, page 1 of 2
Poi for Mama: a Pilot to Improve Maternal Microbiome and Gestational Diabetes Risk
NCT07446205
Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
NCT07075120
Mobile Health Dietary Intervention for Stroke Survivors With Prediabetes or Type 2 Diabetes
NCT07120334
Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
NCT06935838
Quit-Smoking Study for Native Hawaiians
NCT07075575
The Development and Evaluation of a Culturally Grounded ENDS Intervention for Rural Hawaiian Youth
NCT06929520
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
NCT06237816
'Ai Pono Cooking Demonstrations
NCT06526650
PILI 'Āina Household
NCT06526273
mHealth to Improve Diet Quality Among Early Adolescents in SNAP-Ed in Hawaii
NCT06360367
Natives Engaged in Alzheimers Research - 'Ike Kupuna
NCT05534607
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis
NCT05369546
The Healthy Diet and Lifestyle Study II
NCT05132686
Improving Quality of Life for Colon Cancer Patients and Their Caregivers
NCT04713007
TSR-022 (anti-TIM-3 Antibody) and TSR-042 (anti-PD-1 Antibody) in Patients with Liver Cancer
NCT03680508
Exercise Post-Diagnosis of Breast Cancer
NCT04013568
Navigating Hypertension and Food Insecurity
NCT07544836
A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status
NCT07038317
The Ku Ola Project: Enhancing Health Promotion Among Native Hawaiian Men.
NCT06964633
Barriers/Facilitators and Care Coordination of Native Hawaiians & Kidney Disease
NCT06843603
Parkinson's Improvement Activated by Hula Understanding
NCT06543810
Household Participants
NCT06590649
Peau o le Vasa: Analysis of the Efficacy and Feasibility of the PILI Lifestyle Program (PLP) + Social Determinants of Health (SDOH) Intervention and Adaptation of SDOH Measures Pilot Study
NCT06471595
Keiki (Pediatric) Produce Prescription (KPRx) Program Hawaii
NCT05442424
Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation
NCT04651166
Video Education to Improve Rural Cancer Care Delivery
NCT05162404
Pediatric Physical Activity for Children With Cancer
NCT06012825
INvestigating TELmisartin Study
NCT04715763
Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients
NCT04360551
Preclinical Medical Student Echocardiography Training American Society of Echocardiography Curriculum
NCT04083924
Mobile Mindfulness Meditation Intervention to Improve the Well-Being of Cancer Survivors
NCT03581357
Validation of an Oncology-specific Instrument to Measure Care Coordination
NCT03594006
Modifying Physical Activity and Sedentary Time in Filipino Faith Leaders
NCT03439852
Preventing Excessive Gestational Weight Gain Via Short Mobile Messages in WIC
NCT04330976
Buffered Lidocaine in Paracervical Blocks
NCT03107754
Shape Up! Kids Study
NCT03706612
Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration
NCT03057041
Clinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer
NCT03024216
The Impact of Teacher Nonverbal Behaviors on Children's Intergroup Attitudes and Mental Health
NCT03584230
Shape Up! Adults Study
NCT03637855
Efficiency of Task Switching and Multi-tasking
NCT03685266
Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases
NCT02758132
Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer
NCT02648919
Non-Pharmacologic Patient Centered Pain Control Adjuncts During First Trimester Abortion
NCT02590146
Maraviroc and NeuroAIDS Pathogenesis
NCT02159027
Prophylactic Pregabalin to Decrease Pain During Medical Abortion
NCT02782169
Paracervical Block for Pain Associated With Laminaria Insertion
NCT02454296
Online Intervention for ANHPI College Students
NCT02318849
Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation
NCT02083809
Hawaii Patient Reward And Incentives to Support Empowerment
NCT02123251
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 11 |
| Phase 3 | 2 |
| Phase 4 | 2 |
What is open in the University of Hawaii pipeline
13 recruiting of 77 indexed (17% open); 51 completed (66%).
Phase mix: 4 late (III/IV) vs 14 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Hawaii: open-pipeline peers nationwide
Peers matched on 77 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
University of Hawaii sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 77 trials (± recruiting share)
- U.S. Army Medical Research and Development Command · 77 trials · 4% recruiting
- RAND · 78 trials · 8% recruiting
- Ionis Pharmaceuticals · 76 trials · 12% recruiting
- MetroHealth Medical Center · 76 trials · 13% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Penn State University · 17% recruiting · 219 trials
- University of Utah · 17% recruiting · 818 trials
- CSL Behring · 17% recruiting · 71 trials
- AdventHealth · 17% recruiting · 95 trials
Related
What to do with this University of Hawaii page
77 registered trials is a research-attention snapshot, not an endorsement of University of Hawaii or any single study.
- 13 of University of Hawaii's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition University of Hawaii studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Hawaii pipeline card: 77 registered trials from official public datasets.Report a data error.